Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-446-3 | CAS number: 95-74-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Several acute oral studies are available. In the most reliable study (Kimmerle, 1972), a LD50 (rat) of 1053 mg/kg bw was found.
In the acute inhalation study, a LC50(rat) > 7.69 mg/L was detected (maximal examined concentration).
The acute dermal LD50 (rat) (4 hours exposure) was 650 µl 3-chloro-p-toluidine/kg bw (= ca. 765 mg/kg bw).
3-chloro-p-toluidine causes methemoglobinemia.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No OECD guideline or GLP defined.
- Principles of method if other than guideline:
- Acute oral toxicity study in male rats.
- GLP compliance:
- not specified
- Test type:
- other: Acute oral toxicity in rats
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Route of administration:
- oral: gavage
- Vehicle:
- other: Lutrol
- Doses:
- 100, 250, 500, 950, 1000, 1100, 1150, 1300 mg/kg bw.
- No. of animals per sex per dose:
- 15
- Control animals:
- not specified
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 053 mg/kg bw
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD 50 was 1053 mg/kg bw.
- Executive summary:
In an acute oral toxicity test in male Wister rats the animals were administered by gavage with the test substance dissolved in Lutrol.
The doses tested were: 100, 250, 500, 950, 1000, 1100, 1150, 1300 mg/kg bw.
The animals showed cyanosis, labored breathing, sedative effects and a clearly diminuated general condition after 30 min after the oral application. The signs of intoxication could be observed 4 -7 days. The timepoint of death occurred within 48 hours.
The LD 50 was 1053 mg/kg bw.
Reference
Results:
Dose (mg/kg bw) | Toxicological result after 14 days | Signs of intoxications | Timepoint of death after days | |||
Nr. of death animals | Nr. of animals with symptoms | Nr. of animals used | Start | Endpoint | ||
100 | 0 | 0 | 15 | - | - | - |
250 | 0 | 15 | 15 | 30 min | 4 days | - |
500 | 0 | 15 | 15 | 15 min | 7 days | - |
950 | 3 | 15 | 15 | 10 min | 7 days | 1 day |
1000 | 3 | 15 | 15 | 8 min | 7 days | 1 -2 days |
1100 | 9 | 15 | 15 | 6 min | 7 days | 1 -2 days |
1150 | 13 | 15 | 15 | 5 min | 7 days | 1 -2 days |
1300 days | 15 | 15 | 15 | 4 min | - | 1 day |
The animals showed cyanosis, labored breathing, sedative effects and a clearly diminuated general condition after 30 min after the oral application. The signs of intoxication could be observed 4 -7 days. The timepoint of death occurred within 48 hours.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 053 mg/kg bw
- Quality of whole database:
- Scientifically acceptable and sufficient documented.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Principles of method if other than guideline:
- Six groups of 5 male and 5 female Wistar rats were nose/head-only exposed to analytical concentrations of 0, 375.6, 906.5, 1968.9, 3292.8 or 7619.5 mg 3-chloro-p-toluidine/m³ air for 4 hours. The animals were observed for mortality, weight and clinical signs through day 14. A gross necropsy was performed.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- other: polyethylenglycol - ethanol 1:1
- Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 0, 375.6, 906.5, 1968.9, 3292.8 or 7619.5 mg 3-chloro-p-toluidine/m³ air.
- No. of animals per sex per dose:
- 5 male and 5 female rats/dose
- Control animals:
- yes
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 7.62 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Interpretation of results:
- GHS criteria not met
- Executive summary:
Six groups of 5 male and 5 female Wistar rats were nose/head-only exposed to analytical concentrations of 0, 375.6, 906.5, 1968.9, 3292.8 or 7619.5 mg 3-chloro-p-toluidine/m³ air for 4 hours. The animals were observed for mortality, weight and clinical signs through day 14. A gross necropsy was performed.
At 7620 mg 3-chloro-p-toluidine/m³ air (maximal examined concentration) one of five female rats died. Clinical signs were a low irritation potential of mucuous membranes, methamoglobinemia and unspecific central nervous symptoms.
LC50 > 7.69 mg/L.
Reference
At 7620 mg 3-chloro-p-toluidine/m³ air (maximal examined concentration) one of five female rats died. Clinical signs were a low irritation potential of mucuous membranes, methamoglobinemia and unspecific central nervous symptoms.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 7 690 mg/m³ air
- Quality of whole database:
- GLP guideline study.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: scientifically acceptable and sufficinet documented
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Principles of method if other than guideline:
- Undiluted 3-chloro-p-toluidine was applied on the shaved belly skin of rats for 4 hours in doses of 100 to 1000 µl/kg (117 to 1170 mg/kg). After 4 hours the substance was removed with water and soap. The animals were observed for 7 days.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Type of coverage:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Duration of exposure:
- 4 hours
- Doses:
- 100 µl (= 117 mg)/kg bw, 250 µl (= 292.5 mg/kg bw), 500 µl (= 585 mg/kg bw), 600 µl (= 702 mg/kg bw), 800 µl (= 936 mg/kg bw), 1000 µl (= 1170 mg/kg bw).
- No. of animals per sex per dose:
- 5 rats (100 µl), 5 rats (250 µl), 10 rats (500 µl), 10 rats (600 µl), 10 rats (800 µl), 5 rats (1000 µl).
- Control animals:
- no
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 765 mg/kg bw
- Based on:
- test mat.
- Executive summary:
Undiluted 3-chloro-p-toluidine was applied on the shaved belly skin of rats for 4 hours in doses of 100 to 1000 µl/kg (117 to 1170 mg/kg bw). After 4 hours the substance was removed with water and soap. The animals were observed for 7 days.
LD50 (4 hours exposure) = 650 µl 3-chloro-p-toluidine/kg bw (= ca. 765 mg/kg bw).
Reference
From 2 to 6 hours after application of the test substance,typical signs of intoxication (cyanosis, laboured breathing, sedation) were observed. The highest dose without findings was 100 µl (117 mg/kg bw) and the lowest lethal dose was 600 µl (702 mg/kg bw).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 765 mg/kg bw
- Quality of whole database:
- Scientifically acceptable and sufficinet documented.
Additional information
Justification for classification or non-classification
In the acute oral toxicity study (key study) a LD50 (rat) of 1053 mg/kg bw was found.
In the acute inhalation study, a LC50(rat) > 7.69 mg/L was detected (maximal examined concentration).
The acute dermal LD50 (rat) (4 hours exposure) was 650 µl 3-chloro-p-toluidine/kg bw (= ca. 765 mg/kg bw).
3-chloro-p-toluidine causes methemoglobinemia. Therefore the classification is raised by one grade.
According to CLP classification criteria (Regulation (EC) No 1272/2008) a classification as Acute Tox. 3 ( H301: Toxic if swallowed), Acute Tox. 4 ( H332: Harmful if inhaled) and Acute Tox. 2 ( H310: Fatal in contact with skin) is proposed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
